Vaccine Clinical Trials in Partnership with Novavax
In January 2021, Howard University announced its participation as a Phase 3 COVID-19 clinical trial site to evaluate a new coronavirus vaccine developed by Novavax, a Maryland-based biotechnology company. This clinical trial expects to include proportional representation among diverse populations most vulnerable to COVID-19.
Tracing Loss of Smell and COVID-19
In March 2020, reports connected the loss of smell to COVID-19 infections, forcing smell researchers from around the world to take notice, including Thomas Heinbockel, Ph.D., a Howard University professor and researcher.
Last year, Howard University and NIH launched a research investigator development pilot program and pledged to find ways for greater collaboration on scientific projects.
The Genome Center at the Howard University College of Medicine is working on a research investigation with NIH to learn more about genetic susceptibility and COVID-19.
Wastewater Testing for COVID-19
Assistant Professor of Civil and Environmental Engineering Jeseth Delgado Vela, Ph.D., is part of a team of researchers who are collaborating on nationwide efforts to monitor SARS-CoV-2 particles, the virus responsible for causing COVID-19, in wastewater.